You are here
Preserving the Scientific Integrity of Getting to COVID-19 Vaccines: From Clinical Trials to Public Allocation A Johns Hopkins University-University of Washington Symposium October 6, 2020 1:30 – 4:45 p.m. ET
Primary tabs
Preserving the Scientific Integrity of Getting to COVID-19 Vaccines: From Clinical Trials to Public Allocation A Johns Hopkins University-University of Washington Symposium October 6, 2020 1:30 – 4:45 p.m. ET
Mon, 2020-10-05 14:42 — mike kraftPreserving the Scientific Integrity of Getting to COVID-19 Vaccines: From Clinical Trials to Public Allocation
A Johns Hopkins University-University of Washington Symposium
October 6, 2020 1:30 – 4:45 p.m. ET
Efforts to develop COVID-19 vaccines are well underway, and protecting the scientific integrity of the process is paramount. The trials must be—and must be seen to be—free of political interference, carried out with the highest scientific and ethical rigor, and allowed to proceed until the safety and efficacy of each candidate vaccine has been thoroughly assessed. The ultimate goal is global distribution of and equitable access to effective vaccines that can help slow, and eventually end, the pandemic.
With this backdrop, Johns Hopkins University and the University of Washington are bringing together leading experts to explore these issues and put forward a concise plan for protecting the scientific integrity of these lifesaving efforts. “Preserving the Scientific Integrity of Getting to COVID-19 Vaccines: From Clinical Trials to Public Allocation” will feature insights from global leaders in vaccine science, health metrics, policy, regulation, and communications. ...
Click on to link to register and see list of speakers.
Recent Comments